Search results for " heart."

showing 10 items of 733 documents

Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study

2017

Abstract Background Mitoxantrone (MX) has been used as second line therapy for aggressive multiple sclerosis (MS). Potential cardiotoxic effects of MX limit its use; a cumulative dose of up to 100 mg/m2, has been long considered relatively safe. We calculated the frequency of cardiac side effects in MS patients treated with MX. Methods We performed a cohort study including all MS patients treated with MX at the Neurological Department of the University Hospital of Palermo, Italy. Two hundred-sixty-four MS patients diagnosed according to validated criteria were included and followed-up until the end of September 2010. Patients were treated with MX as a second line therapy if they had no prev…

medicine.medical_specialtyImmunologyHeart failureComorbidity030204 cardiovascular system & hematologylcsh:RC346-429Multiple sclerosis03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and AllergyMyocardial infarctionlcsh:Neurology. Diseases of the nervous systemMitoxantroneEjection fractionmedicine.diagnostic_testCumulative dosebusiness.industryComorbidity Multiple sclerosis Heart failure Mitoxantrone Therapymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareNeurologyHeart failureCohortPhysical therapySettore MED/26 - NeurologiaTherapyNeurology (clinical)MitoxantronebusinessElectrocardiography030217 neurology & neurosurgeryCohort studymedicine.drug
researchProduct

Intrarenal venous flow in cardiorenal syndrome: a shining light into the darkness

2018

The aim of this case report is to assess the potential role of intrarenal Doppler ultrasonography as a non‐invasive method to evaluate intrarenal venous flow (IRVF) in acute heart failure (AHF) and concomitant renal dysfunction. We report a case of an 81‐year‐old woman with valvular heart disease (previous mitral valve replacement) that presented with acutely decompensated heart failure and concomitant worsening renal function (WRF). In addition to complete physical examination, laboratory analysis, and echocardiography, IRVF was assessed at baseline and 48 h after the administration of diuretic treatment. At admission, physical examination and echocardiography revealed signs of intravascul…

medicine.medical_specialtyKidneyCreatininebusiness.industrymedicine.medical_treatmentvalvular heart diseaseMitral valve replacementRenal functionCardiorenal syndrome030204 cardiovascular system & hematologymedicine.diseaseInferior vena cava03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicine.anatomical_structuremedicine.veinchemistryHeart failureInternal medicinemedicineCardiology030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessESC Heart Failure
researchProduct

Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction

2019

Aim: To evaluate the long-term outcome of patients with Takotsubo syndrome (TTS) and severely reduced left ventricular ejection fraction (LVEF ≤ 35%) at presentation. Methods and results: The study population included 326 patients (mean age 69.5 ± 10.7 years, 28 male) with TTS enrolled in the Takotsubo Italian Network, divided into two groups according to LVEF (≤ 35%, n = 131; > 35%, n = 195), as assessed by transthoracic echocardiography at hospital admission. In-hospital events were recorded in both groups. At long-term follow-up (median 26.5 months, interquartile range 18–33), composite major adverse cardiac events (MACE: cardiac death, acute myocardial infarction, heart failure, and …

medicine.medical_specialtyLeft ventricular ejection fractionCardiomyopathyHeart failure030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicinemedicinecardiovascular diseasesMyocardial infarctionCardiogenic shock; Cardiomyopathy; Heart failure; Left ventricular ejection fraction; Takotsubo syndromeCardiogenic shockEjection fractionbusiness.industryCardiogenic shockHazard ratiomedicine.diseaseConfidence intervalHeart failureCardiologybusinessTakotsubo syndromeCardiology and Cardiovascular MedicineCardiogenic shock; Cardiomyopathy; Heart failure; Left ventricular ejection fraction; Takotsubo syndrome; Cardiology and Cardiovascular MedicineMace
researchProduct

Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA(1-64)) in the rat heart

2010

Cytoskeleton scaffold in cardiac myocytes provides structural support and compartmentalization of intracellular components. It is implicated in cardiac pathologies including hypertrophy and failure, playing a key role in the determinism of contractile and diastolic dysfunctions. Chromogranin A (CgA) and its derived peptides have revealed themselves as novel cardiovascular modulators. In humans, normal CgA levels considerably increase in several pathologies, including heart failure. Recent data have shown on the unstimulated rat heart that human recombinant Vasostatin-1 (hrVS-1) and rat chromogranin A 1-64 (rCgA(1-64)) induce negative inotropic and lusitropic effects counteracting the beta-a…

medicine.medical_specialtyMESH: RatsPhysiologyPhalloidin[SDV]Life Sciences [q-bio]Clinical BiochemistryMESH: Myocytes Cardiacmacromolecular substancesBiologyBiochemistryWortmanninCellular and Molecular Neurosciencechemistry.chemical_compoundEndocrinologyInternal medicineMyosinmedicineMESH: CytoskeletonMyocyteMESH: AnimalsCytoskeletonActinMESH: In Vitro TechniquesMESH: HumansSettore BIO/16 - Anatomia UmanaChromogranin AMESH: Rats WistarMESH: MaleCell biologyMESH: Cell LineMESH: Heart[SDV] Life Sciences [q-bio]EndocrinologychemistryInotropismVasostatin Rat CgA1-64 Rat Langendorff heart Inotropy Lusitropy Cardiomyocytes Cytoskeletonbiology.proteinMESH: Chromogranin A
researchProduct

Embryonic and foetal Islet-1 positive cells in human hearts are also positive to c-Kit.

2011

During embryogenesis, the mammalian heart develops from a primitive heart tube originating from two bilateral primary heart fields located in the lateral plate mesoderm. Cells belongings to the pre-cardiac mesoderm will differentiate into early cardiac progenitors, which express early transcription factors which are also common to the Isl-1 positive cardiac progenitor cells isolated from the developing pharyngeal mesoderm and the foetal and post-natal mice hearts. A second population of cardiac progenitor cells positive to c-Kit has been abundantly isolated from adult hearts. Until now, these two populations have been considered two different sets of progenitor cells present in the heart in…

medicine.medical_specialtyMesodermHistologyTime FactorsPopulationLIM-Homeodomain ProteinsBiophysicsembryoReceptors Cell SurfaceBiologyIsl-1; c-Kit; human heart; embryo; foetusAndrologyFetusfoetus.Antigens CDPregnancyInternal medicinec-Kitmental disordersmedicineHumansMyocytes CardiacProgenitor celleducationlcsh:QH301-705.5Fetuseducation.field_of_studyOriginal PaperLateral plate mesodermMyocardiumEmbryogenesisEndoglinInfant NewbornEmbryoHeartCell BiologyEmbryonic stem cellImmunohistochemistryfoetusProto-Oncogene Proteins c-kitEndocrinologymedicine.anatomical_structureIsl-1 c-Kit human heart embryo foetuslcsh:Biology (General)Isl-1Femalehuman heartpsychological phenomena and processesTranscription FactorsEuropean journal of histochemistry : EJH
researchProduct

Stay Home, Stay Active with SuperJump®: A Home-Based Activity to Prevent Sedentary Lifestyle during COVID-19 Outbreak

2020

The purpose of this study was to investigate the intensity of SuperJump® workout as a home-based activity for fulfilling physical activity recommendations during COVID-19 home-confinement. Seventeen (males: n = 10; females: n = 7) college students (age: 25.8 ± 2.7 years; height: 1.7 ± 0.1 m; weight: 66.2 ± 12.1 kg) participated in the study. To assess the intensity of the activity (30-min), heart rate (HR), expressed as percentages of age-predicted maximal HR (%HRmax), and session ratings of perceived exertion (sRPE), collected on a CR10 scale, were used. %HRmax data were categorically separated in five classes of intensity according to the American College of Sport…

medicine.medical_specialtyMini-trampolineCoronavirus disease 2019 (COVID-19)Geography Planning and DevelopmentHeart rateTJ807-830Perceived exertionManagement Monitoring Policy and LawTD194-195Renewable energy sources03 medical and health sciences0302 clinical medicineHeart ratehome training; coronavirus; exercise; heart rate; mini-trampoline; rate of perceived exertionmedicineGE1-350030212 general & internal medicineExerciseSedentary lifestyleEnvironmental effects of industries and plantsRenewable Energy Sustainability and the Environmentbusiness.industryHome trainingRate of perceived exertionRepeated measures design030229 sport sciencesHome basedIntensity (physics)Environmental sciencesCoronavirusCoronavirus; Exercise; Heart rate; Home training; Mini-trampoline; Rate of perceived exertionPhysical therapyExercise intensitybusinesshuman activitiesSustainability; Volume 12; Issue 23; Pages: 10135
researchProduct

Mitral valve therapy still surgical?

2015

Mitral regurgitation (MR) is the second most common valvular heart disease after aortic valve stenosis. With increased understanding of the heterogenic pathophysiology of MR, cardiac surgeons have developed various techniques that increase the likelihood of successful mitral valve repair (MVR). Nowadays, a rate of repair >90% may be reached in some mitral valve reference centres. In recent years, the introduction of transcatheter mitral valve intervention techniques has opened up new frontiers in mitral therapy, specifically in patients at high risk for standard surgery. Current percutaneous technologies for MVR have been developed on the basis of some of the surgical principles. Based on c…

medicine.medical_specialtyMitral valve repairMitral regurgitationPercutaneousbusiness.industryClinical outcomemedicine.medical_treatmentStandard treatmentMitraClipNew devicevalvular heart diseasemedicine.diseasemedicine.anatomical_structureAortic valve stenosisInternal medicineMitral valvecardiovascular systemmedicineCardiologyTranscatheter mitral valve therapybusinessCardiology and Cardiovascular MedicineMitral valve repairLong-term repair result
researchProduct

RELEASE OF CATECHOLAMINES FROM THE HEART

1966

Publisher Summary This chapter discusses the release of catecholamines from the heart. The isolated heart of the rabbit with the sympathetic nervous supply from the right stellate ganglion intact was set up according to Hukovio and Muscholl. The ganglion was stimulated for 30 s at supramaximal voltage with rectangular impulses of 3–5 ms duration a frequency of 10 shocks/s. Each stimulation period was followed by a resting period of 30 s. In the rabbit, four doses of 50 mg/kg l-α-methyldopa decreased the noradrenaline concentration in auricles, right, and left ventricles by 38–60%. An equimolar amount of α-methyl noradrenaline was detected in the tissues. Reserpine and guanethidine in doses,…

medicine.medical_specialtyMonoamine oxidaseChemistryStimulationIsolated heartLeft VentriclesReserpineGanglionEndocrinologymedicine.anatomical_structureStellate ganglionInternal medicinemedicineGuanethidinemedicine.drug
researchProduct

Transcatheter Vs. Surgical Closure of Atrial Septal Defects in Adults

2018

Abstract Percutaneous transcatheter device closure of secundum atrial septal defects (ASD) has now largely replaced surgical closure in most centres. The aim of this study was to compare results of transcatheter and surgical ASD closure in adults in Latvia during the years 2002–2014 and to analyse long-term outcomes of transcatheter closure. We analysed data from 334 patients with secundum ASD who underwent ASD closure in Pauls Stradiņš Clinical University Hospital. Patients were included into device or surgical closure groups. In the device group, three follow-ups were made 1, 6, and 12 months after the procedure. No follow-up data were available for surgical arm patients beyond their hosp…

medicine.medical_specialtyMultidisciplinaryGeneral interestgrown-up congenital heart diseaseScienceQClosure (topology)medicineatrial septal defectAtrial septal defectsSurgeryProceedings of the Latvian Academy of Sciences. Section B, Natural Sciences
researchProduct

Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure.

2021

BACKGROUND: The optimal length of stay (LOS) in patients hospitalized for acute heart failure (AHF) remains controversial. Plasma antigen carbohydrate 125 (CA125) has emerged as a reliable proxy of congestion. We aimed to evaluate whether there is a differential impact of LOS on the risk of 6-month AHF readmission across CA125 levels. METHODS: This is a retrospective study that included 1,387 patients discharged for AHF in two third-level centers. CA125 was measured 48±24h after admission. The association between CA125 and LOS with the risk of subsequent AHF readmission at 6 months was analyzed by Cox regression analysis accounting for death as a competing event. RESULTS: The median (IQR) a…

medicine.medical_specialtyMultivariate analysisendocrine system diseasesacute heart failureCarbohydrates030204 cardiovascular system & hematologyVentricular Function LeftCA12503 medical and health sciences0302 clinical medicinelength of stayAntigenInternal medicineInternal MedicineHumansMedicineIn patient030212 general & internal medicineAgedRetrospective StudiesDifferential impactAged 80 and overHeart FailureEjection fractionbusiness.industryProportional hazards modelStroke VolumeRetrospective cohort studyLength of StayPrognosismedicine.diseasefemale genital diseases and pregnancy complicationsHeart failureAcute DiseaseFemalebusiness
researchProduct